McKesson launches venture fund

Laura Pedulli | | Health Exec | Artificial Intelligence

McKesson has launched a strategic venture capital fund to invest in early and growth stage companies that are addressing current and emerging healthcare business challenges.

The fund, McKesson Ventures, will make minority investments in companies that span a broad section of healthcare. The fund is interested in businesses that are driving towards a stronger, more sustainable future for healthcare and will target companies that are both enabling and benefitting from the disruptive changes affecting the industry, according to a press release.

The target companies will predominantly be pursuing high growth opportunities adjacent to or outside McKesson’s current business.

McKesson Ventures will be managed by Tom Rodgers, who previously led venture investing efforts at Cambia Health.

“McKesson Ventures will help us support the development and commercialization of innovations taking place across healthcare,” said John Hammergren, chairman and CEO, McKesson, in a statement. “By investing and partnering with entrepreneurs and other investors that can bring new approaches to the challenges our customers are facing, we will accelerate the innovation cycle and further strengthen the value we provide to industry stakeholders across all segments.”

Visit the fund’s website for more information. 

Laura Pedulli

Related Content

5 ways to let AI raise patient satisfaction, elevate provider performance
Medtronic using AI to identify more TAVR patients in need
When life sciences met artificial intelligence
AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."